PF-06454589
Catalog Number | Pack Size | List Price* | Quantity | |
---|---|---|---|---|
HY-112855-5MG | 5 mg | 133,00 | Add | |
HY-112855-1ML | 10mM/1mL | 146,00 | Add | |
HY-112855-10MG | 10 mg | 204,00 | Add | |
HY-112855-25MG | 25 mg | 368,00 | Add | |
HY-112855-50MG | 50 mg | 545,00 | Add | |
HY-112855-100MG | 100 mg | 837,00 | Add | |
HY-112855-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
PF-06447475 is a highly potent, selective, brain penetrant LRRK2 kinase inhibitor with IC50 values of 3 nM and 11 nM for WT LRRK and G2019S LRRK2, respectively. PF-06447475 can be used for parkinson's disease (PD) research[1].
Category | Protein |
Supplier | MedChem Express |
Regulatory Status | RUO |
Research Field | Neurological Disease, Autophagy |
Format | Solubility: DMSO : 15.62 mg/mL (ultrasonic;warming;heat to 60°C) |
Grade | Clinical information: No Development Reported |
Purity | 99.73% |
Molecular Formula | C14H16N6O |
Molecular Weight | 284.32 |
CAS-Number | 1527473-30-8 |
Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
Tech. Data Sheet | View datasheet |
Link To Supplier | http://www.medchemexpress.com |
Shipping Details | Room Temperature |
Material Safety Data Sheet | Download PDF |